Total Payments
$14,416
2024 Payments
$1,704
Companies
43
Transactions
614
Medicare Patients
19,345
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$13,858 (96.1%)
Other$350.00 (2.4%)
Education$207.48 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,858 | 609 | 96.1% |
| Honoraria | $350.00 | 1 | 2.4% |
| Education | $207.48 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,787 | 76 | $0 (2024) |
| PFIZER INC. | $1,170 | 67 | $0 (2024) |
| LEO Pharma Inc. | $843.30 | 48 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $826.80 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $747.34 | 22 | $0 (2024) |
| Amgen Inc. | $717.62 | 26 | $0 (2024) |
| Dermavant Sciences, Inc. | $697.29 | 33 | $0 (2024) |
| UCB, Inc. | $644.75 | 23 | $0 (2024) |
| Biofrontera Inc. | $572.07 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $571.17 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,704 | 91 | ABBVIE INC. ($234.12) |
| 2023 | $2,025 | 74 | PFIZER INC. ($267.55) |
| 2022 | $2,002 | 71 | ABBVIE INC. ($385.57) |
| 2021 | $1,335 | 70 | Janssen Biotech, Inc. ($183.59) |
| 2020 | $1,101 | 57 | AbbVie Inc. ($201.41) |
| 2019 | $1,553 | 48 | AbbVie, Inc. ($381.79) |
| 2018 | $2,726 | 97 | Biofrontera Inc. ($480.01) |
| 2017 | $1,970 | 106 | Aqua Pharmaceuticals ($552.34) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Immunology | ||||||
| 11/13/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Immunology | ||||||
| 10/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,995 | 8,077 | $2.0M | $465,803 |
| 2022 | 23 | 5,248 | 12,508 | $2.1M | $488,900 |
| 2021 | 24 | 4,802 | 13,439 | $1.9M | $452,965 |
| 2020 | 21 | 4,300 | 7,297 | $1.6M | $380,196 |
Total Patients
19,345
Total Services
41,321
Medicare Billing
$1.8M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 892 | 1,227 | $368,100 | $77,546 | 21.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 297 | 532 | $228,111 | $68,114 | 29.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 434 | 616 | $221,409 | $60,758 | 27.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 575 | 734 | $195,244 | $60,434 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 455 | $159,250 | $41,853 | 26.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 532 | 650 | $165,750 | $37,008 | 22.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 530 | 983 | $281,138 | $26,774 | 9.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 403 | 543 | $102,518 | $18,371 | 17.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 197 | 397 | $59,550 | $16,128 | 27.1% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 64 | 73 | $43,508 | $12,409 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 136 | 136 | $68,000 | $10,738 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $33,500 | $7,307 | 21.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 277 | 1,297 | $25,960 | $6,683 | 25.7% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 28 | 32 | $14,530 | $4,854 | 33.4% |
| 67810 | Biopsy of eyelid | Office | 2023 | 29 | 30 | $15,419 | $4,238 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 68 | 80 | $14,000 | $3,235 | 23.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 27 | 28 | $7,756 | $2,530 | 32.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 18 | $7,399 | $2,266 | 30.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 35 | 80 | $13,440 | $1,960 | 14.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 15 | 24 | $6,864 | $1,649 | 24.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 26 | 31 | $4,185 | $912.74 | 21.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 44 | $1,100 | $35.28 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 839 | 1,130 | $339,000 | $70,960 | 20.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 451 | 649 | $233,270 | $64,846 | 27.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 270 | 484 | $207,530 | $63,239 | 30.5% |
About Lawrence Strong
Lawrence Strong is a Procedural Dermatology healthcare provider based in Wellington, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609918671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lawrence Strong has received a total of $14,416 in payments from pharmaceutical and medical device companies, with $1,704 received in 2024. These payments were reported across 614 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($13,858).
As a Medicare-enrolled provider, Strong has provided services to 19,345 Medicare beneficiaries, totaling 41,321 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Wellington, FL
- Active Since 02/13/2007
- Last Updated 01/22/2009
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1609918671
Products in Payments
- EUCRISA (Drug) $934.57
- DUPIXENT (Biological) $905.30
- SKYRIZI (Biological) $872.66
- Otezla (Drug) $761.89
- VTAMA (Drug) $697.29
- COSENTYX (Biological) $649.35
- Ameluz (Drug) $480.01
- Erivedge (Biological) $476.10
- ADBRY (Biological) $471.16
- Humira (Biological) $368.99
- Cimzia (Drug) $343.33
- TREMFYA (Drug) $329.65
- OPZELURA (Drug) $310.71
- Bimzelx (Biological) $301.42
- ENSTILAR (Drug) $291.51
- ILUMYA (Biological) $267.88
- Enbrel (Biological) $263.45
- Xolegel (Drug) $242.28
- CIBINQO (Drug) $235.37
- Winlevi (Drug) $219.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.